BASF to Develop a High Purity Poloxamer for Mast Therapeutics

Go back to BASF to Develop a High Purity Poloxamer for Mast Therapeutics
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 13.55 --0 (-0%)
Previous Close $13.55    52 Week High $0.71 
Open $13.55    52 Week Low $0.07 
Day High $13.55    P/E N/A 
Day Low $13.55    EPS $-0.35 
Volume 1,098,380       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 13.55 --0 (-0%)
Previous Close $13.55    52 Week High $0.71 
Open $13.55    52 Week Low $0.07 
Day High $13.55    P/E N/A 
Day Low $13.55    EPS $-0.35 
Volume 1,098,380